Authors: Cass, LM Moore, KHP Dallow, NS Jones, AE Sisson, JR Prince, WT

Citation: Lm. Cass et al., The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers, J CLIN PHAR, 41(5), 2001, pp. 528-535

Authors: Moore, KHP Cass, LM Dallow, N Hardman, TC Jones, A Boyce, M Prince, WT

Citation: Khp. Moore et al., Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers, J CLIN PHAR, 41(10), 2001, pp. 1098-1105

Authors: Moore, KHP Cass, LM Dallow, N Hardman, TC Jones, A Boyce, M Prince, WT

Citation: Khp. Moore et al., Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor, EUR J CL PH, 56(11), 2001, pp. 805-811

Authors: Calfee, DP Peng, AW Cass, LM Lobo, M Hayden, FG

Citation: Dp. Calfee et al., Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection, ANTIM AG CH, 43(7), 1999, pp. 1616-1620